| Literature DB >> 32023525 |
P Kumar Rao1, Christopher Barker2, Daniel G Coit2, Richard W Joseph3, Miguel Materin4, Ramesh Rengan5, Jeffrey Sosman6, John A Thompson5, Mark R Albertini7, Genevieve Boland8, William E Carson Iii9, Carlo Contreras10, Gregory A Daniels11, Dominick DiMaio12, Alison Durham13, Ryan C Fields1, Martin D Fleming14, Anjela Galan15, Brian Gastman16, Kenneth Grossman17, Valerie Guild18, Douglas Johnson19, Giorgos Karakousis20, Julie R Lange, Kim Margolin21, Sameer Nath22, Anthony J Olszanski23, Patrick A Ott24, Merrick I Ross25, April K Salama4, Joseph Skitzki26, Susan M Swetter27, Evan Wuthrick28, Nicole R McMillian29, Anita Engh29.
Abstract
The NCCN Guidelines for Uveal Melanoma include recommendations for staging, treatment, and follow-up of patients diagnosed with uveal melanoma of the choroid or ciliary body. In addition, because distinguishing between uveal melanoma and benign uveal nevi is in some cases difficult, these guidelines also contain recommendations for workup of patients with suspicious pigmented uveal lesions, to clarify the tests needed to distinguish between those who should have further workup and treatment for uveal melanoma versus those with uncertain diagnosis and low risk who should to be followed and later reevaluated. These NCCN Guidelines Insights describe recommendations for treatment of newly diagnosed nonmetastatic uveal melanoma in patients who have already undergone a complete workup.Entities:
Year: 2020 PMID： 32023525 DOI： 10.6004/jnccn.2020.0007
Source DB: PubMed Journal: J Natl Compr Canc Netw ISSN： 1540-1405 Impact factor: 11.908